← Eichor
Study identifier: NCT06731907 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Condition: Non-small Cell Lung Cancer  ·  Sponsor: Merck Sharp & Dohme LLC

PhasePhase 2
Planned participants90
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and lung cancer that has spread beyond surgical removal. Standard treatments include immunotherapy, such as pembrolizumab, and chemotherapy. This study aims to determine the effectiveness of adding other treatments, including the human epidermal growth factor receptor 3-directed antibody-drug conjugate (HER3-DXd) patritumab deruxtecan, to pembrolizumab, with or without chemotherapy. The primary goals are to assess safety and efficacy of the treatments.

This description comes directly from the study's public registry record.

Talk to the study team

Toll Free Number  ·  1-888-577-8839  ·  Trialsites@msd.com

Always discuss trial participation with your own doctor first.

Locations (41)

University of Kentucky ( Site 0019)Lexington, Kentucky, United StatesRecruiting
MedStar Franklin Square Medical Center ( Site 0033)Baltimore, Maryland, United StatesRecruiting
Sanford Fargo Medical Center ( Site 0039)Fargo, North Dakota, United StatesRecruiting
Abramson Cancer Center ( Site 0010)Philadelphia, Pennsylvania, United StatesRecruiting
Sanford Cancer Center ( Site 0038)Sioux Falls, South Dakota, United StatesRecruiting
Centro de Estudios Clínicos SAGA ( Site 0162)Santiago, Region M. de Santiago, ChileRecruiting
FALP ( Site 0161)Santiago, Region M. de Santiago, ChileRecruiting
Bradfordhill ( Site 0160)Santiago, Region M. de Santiago, ChileRecruiting
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 0204)Athens, Attica, GreeceRecruiting
European Interbalkan Medical Center-Oncology Department ( Site 0205)Thessaloniki, GreeceRecruiting
Petz Aladar Egyetemi Oktato Korhaz ( Site 0062)Győr, Győr-Moson-Sopron, HungaryRecruiting
Jasz-Nagykun-Szolnok Varmegyei Hetenyi Geza Korhaz-Rendelointezet ( Site 0061)Szolnok, Jász-Nagykun-Szolnok, HungaryRecruiting

+ 29 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06731907